Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes.
about
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia TherapyEngineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Potential for layered double hydroxides-based, innovative drug delivery systemsPolymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs.In vivo imaging of multidrug resistance using a third generation MDR1 inhibitor.Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinibPluronics and MDR reversal: an update.Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrierExpression and localization of p-glycoprotein, multidrug resistance protein 4, and breast cancer resistance protein in the female lower genital tract of human and pigtailed macaque.Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancerEnhanced activity of doxorubicin in drug resistant A549 tumor cells by encapsulation of P-glycoprotein inhibitor in PLGA-based nanovectors.Multidrug resistance: Physiological principles and nanomedical solutions.Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance.Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment.Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic-Inorganic Hybridization into Frameworks.Nano-based strategies to overcome p-glycoprotein-mediated drug resistance.P-glycoprotein inhibition of drug resistant cell lines by nanoparticles.Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma.The Effect of Absorption-Enhancement and the Mechanism of the PAMAM Dendrimer on Poorly Absorbable Drugs
P2860
Q26780502-DA6A9B3D-BEF7-4C44-A755-C9EB57966D76Q28073956-268C5CD4-AADE-4492-BCF8-A093CF3CD2C0Q30391504-A46CB7AD-6461-4477-908B-E13D4B8F0A2FQ30451024-CDA5BF59-26C2-401F-8E8A-97BF81A085EFQ30583710-6A4FF2A3-A9C8-4309-BAA5-4BD1D7432911Q33654186-4706FD1E-C05B-4D94-A7DB-A99A8F78058DQ34005678-0B63814D-F300-416E-8AED-DE2612955654Q34075276-462FE61B-A8DD-4760-87FC-B7002FC84BC3Q34420654-21C09D7F-A5C9-4B32-9117-737D8A5ADEB6Q35742555-F6AFE2CC-A03C-48A4-8F68-3DF539ED413BQ37438008-98EB9E9D-0FF3-4E66-B50A-87738DE072EBQ38152179-BAB15AB0-AFA3-47F7-B5DD-0C7DA0D04CCDQ38167822-BBB06263-F4C4-47E9-8D9B-2D565BA88D61Q38741022-3883169A-E9F8-461A-85E4-58D066BF3CAEQ38758605-964392A7-61CF-4D0F-A99F-3BF41F19EEF4Q38856533-2737E449-0A5B-49E6-BC2C-8E8C5BECF2FAQ38865055-DC1CCB14-1B6B-4B68-94BA-A91D2DD988AAQ39124020-A7E244C8-8E82-4A14-8149-40A8F8F7F313Q58697242-5334E257-9604-4B58-B9A3-1A01F526A5F1
P2860
Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Delivery of P-glycoprotein sub ...... fficient therapeutic outcomes.
@en
type
label
Delivery of P-glycoprotein sub ...... fficient therapeutic outcomes.
@en
prefLabel
Delivery of P-glycoprotein sub ...... fficient therapeutic outcomes.
@en
P2093
P1476
Delivery of P-glycoprotein sub ...... fficient therapeutic outcomes.
@en
P2093
Alf Lamprecht
Arnaud Béduneau
Rita Nieto Montesinos
Yann Pellequer
P356
10.1016/J.JCONREL.2012.04.034
P407
P577
2012-04-27T00:00:00Z